Current guidance
19 items
Each item compared with the same item in the previous release (Apr 30, 2026). Values in quotation marks are the company’s words.
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Raised | Adjusted Income from Operations, per share | for FY2026 | “at least $30.35” | “at least $30.45” | Filing ↗ |
| Raised | Cigna Healthcare Adjusted Income from Operations, Pre-Tax | for FY2026 | “at least $4,525” | “at least $4,550” | Filing ↗ |
| New | Consolidated adjusted income from operations | for FY2026 | — | “at least $30.45 per share” | Filing ↗ |
| Reiterated | Cigna Healthcare Medical Care Ratio | for FY2026 | “83.7% to 84.7%” | “83.7% to 84.7%” | Filing ↗ |
| Reiterated | Evernorth Adjusted Income from Operations, Pre-Tax | for FY2026 | “at least $6,900” | “at least $6,900” | Filing ↗ |
| Change | Metric | Period | Previous | Now | Source |
|---|---|---|---|---|---|
| Not restated | Adjusted Revenues | for FY2026 | “~$280,000” | — | Filing ↗ |
| Not restated | Adjusted revenues outlook | for FY2026 | “approximately $280.0 billion” | — | Filing ↗ |
| Not restated | Adjusted Effective Tax Rate | for FY2026 | “~19.0%” | — | Filing ↗ |
| Not restated | Adjusted income from operations | for FY2026 | “at least $7.950 billion, or at least $30.25 per share” | — | Filing ↗ |
| Not restated | Adjusted Income from Operations | for FY2026 | “at least $7,950” | — | Filing ↗ |
| Not restated | Adjusted income from operations, per share | for FY2026 | “at least $30.25 per share” | — | Filing ↗ |
| Not restated | Adjusted SG&A Expense Ratio | for FY2026 | “~5.0%” | — | Filing ↗ |
| Not restated | Capital Expenditures | for FY2026 | “~$1,300” | — | Filing ↗ |
| Not restated | Cash Flow from Operations | for FY2026 | “~$9,000” | — | Filing ↗ |
| Not restated | Consolidated adjusted income from operations | for FY2026 | “at least $7.950 billion” | — | Filing ↗ |
| Not restated | Shareholder Dividends | for FY2026 | “~$1,600” | — | Filing ↗ |
| Not restated | The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations | for FY2026 | “at least $30.35 per share” | — | Filing ↗ |
| Not restated | Total Medical Customers | for FY2026 | “~18.1M” | — | Filing ↗ |
Guidance for periods that have not yet ended, at its most recent value, grouped by horizon.
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Adjusted Revenues | “~$280,000” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted revenues outlook | “approximately $280.0 billion” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted Effective Tax Rate | “~19.0%” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted income from operations | “at least $7.950 billion, or at least $30.25 per share” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted Income from Operations | “at least $7,950” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted income from operations, per share | “at least $30.25 per share” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Adjusted Income from Operations, per share | “at least $30.45” | for FY2026 | Company-defined | Apr 30, 2026 | 2 | Filing ↗ |
| Adjusted SG&A Expense Ratio | “~5.0%” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Capital Expenditures | “~$1,300” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Cash Flow from Operations | “~$9,000” | for FY2026 | GAAP-tied | Feb 5, 2026 | 1 | Filing ↗ |
| Cigna Healthcare Adjusted Income from Operations, Pre-Tax | “at least $4,550” | for FY2026 | Company-defined | Feb 5, 2026 | 3 | Filing ↗ |
| Cigna Healthcare Medical Care Ratio | “83.7% to 84.7%” | for FY2026 | Company-defined | Feb 5, 2026 | 3 | Filing ↗ |
| Consolidated adjusted income from operations | “at least $30.45 per share” | for FY2026 | Company-defined | Jul 30, 2026 | 1 | Filing ↗ |
| Consolidated adjusted income from operations | “at least $7.950 billion” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Evernorth Adjusted Income from Operations, Pre-Tax | “at least $6,900” | for FY2026 | Company-defined | Feb 5, 2026 | 3 | Filing ↗ |
| Shareholder Dividends | “~$1,600” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| The Cigna Group's outlook for full year 2026 consolidated adjusted income from operations | “at least $30.35 per share” | for FY2026 | Company-defined | Apr 30, 2026 | 1 | Filing ↗ |
| Total Medical Customers | “~18.1M” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Weighted Average Shares Outstanding (millions) | “261 to 265” | for FY2026 | Company-defined | Feb 5, 2026 | 1 | Filing ↗ |
| Metric | Current value | Period | Measure | First stated | Times stated | Source |
|---|---|---|---|---|---|---|
| Incremental share repurchase authorization | “$6.0 billion” | — | Declared action | Jan 30, 2025 | 1 | Filing ↗ |
| Quarterly dividend | “$1.56 per share” | — | Declared action | Feb 5, 2026 | 1 | Filing ↗ |
| Quarterly dividend per share | “$1.51 per share” | — | Declared action | Jan 30, 2025 | 1 | Filing ↗ |
| Share repurchase authorization | “increase of $6.0 billion in incremental share repurchase authorization, bringing total authorization to $10.3 billion” | — | Declared action | Jan 30, 2025 | 1 | Filing ↗ |
| Total share repurchase authorization | “$10.3 billion” | — | Declared action | Jan 30, 2025 | 1 | Filing ↗ |
Cigna Healthcare Adjusted Income from Operations, Pre-Tax, for FY2026 — every statement across the year, each linked to its filing.
12 companies in Healthcare payers & distributors. What they guide on, and who reported this season.
| UnitedHealth Group | Oct 13, 2026 | 5 changes |
| Cardinal Health | Aug 11, 2026 | 13 changes |
| Cencora | Aug 5, 2026 | 11 changes |
| CVS Health | Aug 5, 2026 | 5 changes |
| McKesson | Aug 5, 2026 | 1 change |
| Labcorp | Jul 30, 2026 | 2 changes |
| The Cigna Group | Jul 30, 2026 | 3 changes |
| Humana | Jul 29, 2026 | 4 changes |
Every metric, every release, eight quarters — the complete record as one table.
| Metric | FY2026 | FY2025 | FY2024 | No period |
|---|---|---|---|---|
| Adjusted Revenues | 2 statements | 1 statement | — | — |
| Adjusted Effective Tax Rate | 1 statement | 1 statement | — | — |
| Adjusted income from operations | 2 statements | 2 statements | — | — |
| Adjusted income from operations, per share | 3 statements | 3 statements | 1 statement | — |
| Adjusted SG&A Expense Ratio | 1 statement | 1 statement | — | — |
The 8 earnings releases this page is built from.
| Filed | Fiscal period | Accession | Guidance items | |
|---|---|---|---|---|
| Jul 30, 2026 | FY2026 Q2 | 0001140361-26-030135 | 5 | Open filing ↗ |
| Apr 30, 2026 | FY2026 Q1 | 0001140361-26-017971 | 5 | Open filing ↗ |
| Feb 5, 2026 | FY2025 Q4 | 0001140361-26-003768 | 18 | Open filing ↗ |
| Oct 30, 2025 | FY2025 Q3 | 0001140361-25-039777 | 4 | Open filing ↗ |
| Jul 31, 2025 | FY2025 Q2 | 0001140361-25-028099 | 4 | Open filing ↗ |
| May 2, 2025 | FY2025 Q1 | 0001140361-25-017006 | 4 | Open filing ↗ |
| Jan 30, 2025 | FY2024 Q4 | 0001140361-25-002386 | 18 | Open filing ↗ |
| Oct 31, 2024 | FY2024 Q3 | 0001140361-24-044674 | 4 | Open filing ↗ |